BUZZ-Australia's Emyria slips on discounted placement** Shares of Emyria Ltd EMD.AX fall as much as 6.1% to A$0.062, their biggest intraday pct loss since November 12
** The early-stage drug developer says firm commitments received to raise A$8 million ($5.19 million) at an issue price of A$0.06 per share
** Offer price at a 9.09% discount to the stock's last close
** Funds will be used for expansion of Emyria's East Coast clinical footprint during CY2026, others
** About 3.9 million shares traded, 1.4x the 30-day average
** YTD, stock up 83.4%, including current session's move
($1 = 1.5427 Australian dollars)
(Reporting by Ananya Verma in Bengaluru)
((ananya.verma@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.